hdr

YU238259 is a novel inhibitor of homology-dependent DNA repair(HDR), but does not inhibit non-homologous end-joining (NHEJ), in cell-based GFP reporter assays.

L755507 is an effective, selective agonist of β3-AR(IC50=35 nM).

CAM 833 is an effective orthosteric inhibitor of the BRCA2-RAD51 interaction, inhibiting RAD51 aggregation, enhancing DNA damage-induced apoptosis, increasing 4N cell cycle arrest, and disrupting homologous DNA repair (HDR), and can be used for cancer therapy.

SCR7 pyrazine (SCR7) enhances CRISPR-Cas9-mediated homology-directed repair (HDR) efficiency in vitro up to 19-fold. Inhibits nonhomologous end-joining (NHEJ).

PolQi2 is a Polθ inhibitor that suppresses the helicase activity of Polθ. It can be combined with AZD7648 to enhance HDR-mediated integration and editing accuracy.

KWWCRW is an inhibitory peptide targeting the Holliday junction, exhibiting anticancer activity. It inhibits homologous recombination repair (HDR) during DNA repair by binding to the intermediate structures of the reactive Holliday junction and preventing their resolution. Additionally, KWWCRW inhibits site-specific recombination in vitro in bacteriophages.

LAH5 TFA is an amphipathic cell-penetrating peptide that efficiently delivers CRISPR-Cas9 components into the nuclei of target cells by forming nanocomplexes with RNP and RNP/HDR cargo.